Prescription-event monitoring--recent progress and future horizons.
作者信息
Mann R D
机构信息
Drug Safety Research Unit, Bursledon Hall, Southhampton, UK.
出版信息
Br J Clin Pharmacol. 1998 Sep;46(3):195-201. doi: 10.1046/j.1365-2125.1998.00774.x.
Abstract
摘要
相似文献
1
Prescription-event monitoring--recent progress and future horizons.处方事件监测——近期进展与未来展望
Br J Clin Pharmacol. 1998 Sep;46(3):195-201. doi: 10.1046/j.1365-2125.1998.00774.x.
2
FDA turns to electronic "sentinel" to flag prescription drug safety problems.美国食品药品监督管理局借助电子“哨兵”来标记处方药安全问题。
JAMA. 2008 Jul 9;300(2):156-7. doi: 10.1001/jama.300.2.156.
3
Prescription-event and other forms of epidemiological monitoring of side-effects in the UK.英国的处方事件监测及其他形式的副作用流行病学监测。
Clin Exp Allergy. 1999 Jul;29 Suppl 3:217-39. doi: 10.1046/j.1365-2222.1999.0290s3217.x.
4
Prescription-event monitoring: methodology and recent progress.
J Clin Epidemiol. 1990;43(5):509-22. doi: 10.1016/0895-4356(90)90140-k.
5
Postmarketing surveillance of adverse reactions to drugs.药品不良反应的上市后监测。
Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1155-6. doi: 10.1136/bmj.288.6424.1155.
6
Wonder vigilance.
Drug Saf. 2010 Feb 1;33(2):83-6. doi: 10.2165/11532300-000000000-00000.
7
Two UK Government proposals bearing on drug safety.
Adverse Drug React Toxicol Rev. 1997 Mar;16(1):1-7.
8
Suspected adverse reactions, 2007.
Vet Rec. 2008 Jul 19;163(3):69-72. doi: 10.1136/vr.163.3.69.
9
The demise of postmarketing surveillance.上市后监测的消亡。
Adverse Drug React Toxicol Rev. 1995 Spring;14(1):7-9.
10
[Safety of medicinal products and reporting of adverse drug reactions].[药品安全性与药品不良反应报告]
Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10.
引用本文的文献
1
Event Monitoring and Evaluation by Community Pharmacists in Japan: A Pilot Study on Fenofibrate and Pemafibrate.日本社区药剂师的事件监测和评估：非诺贝特和 pemafibrate 的初步研究。
Curr Drug Saf. 2022;17(4):350-356. doi: 10.2174/1574886317666220224142511.
2
Detection of adverse drug events in e-prescribing and administrative health data: a validation study.电子处方和行政健康数据中不良药物事件的检测：一项验证研究。
BMC Health Serv Res. 2021 Apr 23;21(1):376. doi: 10.1186/s12913-021-06346-y.
3
Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.蒿甲醚-本芴醇的安全性概况：坦桑尼亚公共卫生设施中的一项队列事件监测研究
Clin Drug Investig. 2016 May;36(5):401-11. doi: 10.1007/s40261-016-0385-z.
4
Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria.在加纳城郊居民区使用手机获取药物安全信息的可行性与成本：一项针对非复杂性疟疾患者的前瞻性队列研究
Malar J. 2015 Oct 19;14:411. doi: 10.1186/s12936-015-0932-8.
5
Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide.奥美沙坦、氨氯地平和氢氯噻嗪固定剂量复方制剂的短期安全性和耐受性
J Clin Diagn Res. 2015 Aug;9(8):OC10-3. doi: 10.7860/JCDR/2015/14054.6366. Epub 2015 Aug 1.
6
A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India.一项关于加替沙星（一种在印度使用的新型氟喹诺酮类药物）效用的处方事件监测研究。
Int J Appl Basic Med Res. 2015 May-Aug;5(2):87-91. doi: 10.4103/2229-516X.157151.
7
Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.不良事件与艾滋病毒暴露后预防的依从性：加纳阿克拉科勒-布教学医院的一项队列研究
BMC Public Health. 2015 Jun 20;15:573. doi: 10.1186/s12889-015-1928-6.
8
A comparison of active adverse event surveillance systems worldwide.全球主动不良事件监测系统的比较。
Drug Saf. 2014 Aug;37(8):581-96. doi: 10.1007/s40264-014-0194-3.
9
Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.加纳城市地区接受疟疾治疗患者的不良事件概况：一项队列事件监测研究。
Drug Saf. 2014 Jun;37(6):433-48. doi: 10.1007/s40264-014-0164-9.
10
Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study.印度引入金刚烷胺、对乙酰氨基酚、马来酸氯苯那敏和去氧肾上腺素固定剂量复方制剂的健康结局与安全性评估：一项处方事件监测研究
Perspect Clin Res. 2012 Apr;3(2):62-5. doi: 10.4103/2229-3485.96447.
本文引用的文献
1
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?
Pharmacoepidemiol Drug Saf. 1998 Aug;7 Suppl 1:S4-10. doi: 10.1002/(sici)1099-1557(199808)7:1+<s4::aid-pds352>3.3.co;2-m.
2
Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy.
Pharmacoepidemiol Drug Saf. 1999 Apr;8 Suppl 1:S9-14. doi: 10.1002/(sici)1099-1557(199904)8:1+<s9::aid-pds406>3.3.co;2-3.
3
Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study).心肌梗死与口服避孕药：英格兰和苏格兰的一项回顾性病例对照研究（“MICA”研究）
Pharmacoepidemiol Drug Saf. 1997 Jul;6(4):283-9. doi: 10.1002/(SICI)1099-1557(199707)6:4<283::AID-PDS270>3.0.CO;2-F.
4
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies.通过观察性队列研究对氟伏沙明、氟西汀、舍曲林和帕罗西汀进行的比较。
Pharmacoepidemiol Drug Saf. 1997 Jul;6(4):235-46. doi: 10.1002/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.0.CO;2-3.
5
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance.1996年的处方事件监测（PEM）——一种非干预性观察性队列药物警戒方法。
Pharmacoepidemiol Drug Saf. 1997 Oct;6 Suppl 3:S5-11. doi: 10.1002/(SICI)1099-1557(199710)6:3+<S5::AID-PDS272>3.0.CO;2-F.
6
Safety of long-term lamotrigine in epilepsy.拉莫三嗪治疗癫痫的长期安全性
Epilepsia. 1997 Aug;38(8):881-6. doi: 10.1111/j.1528-1157.1997.tb01252.x.
7
Severe persistent visual field constriction associated with vigabatrin.与氨己烯酸相关的严重持续性视野缩窄。
BMJ. 1997 Jan 18;314(7075):180-1. doi: 10.1136/bmj.314.7075.180.
8
The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients.
Br J Urol. 1996 Sep;78(3):379-84. doi: 10.1046/j.1464-410x.1996.00091.x.
9
Study of United Kingdom product licence applications containing new active substances, 1987-9.1987 - 199年英国含新活性物质的产品许可申请研究
BMJ. 1991 Jan 26;302(6770):223-5. doi: 10.1136/bmj.302.6770.223.
Zotero 插件